Mesa Laboratories Inc. (NASDAQ:MLAB) Director H Stuart Campbell sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $115.03, for a total transaction of $345,090.00. Following the sale, the director now owns 67,930 shares of the company’s stock, valued at $7,813,987.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Mesa Laboratories Inc. (NASDAQ:MLAB) opened at 117.00 on Friday. The company’s 50-day moving average is $114.83 and its 200 day moving average is $110.90. Mesa Laboratories Inc. has a 12 month low of $77.00 and a 12 month high of $131.88. The company has a market cap of $428.81 million, a price-to-earnings ratio of 42.72 and a beta of 0.66.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 15th. Shareholders of record on Wednesday, November 30th will be issued a dividend of $0.16 per share. The ex-dividend date is Monday, November 28th. This represents a $0.64 annualized dividend and a yield of 0.55%. Mesa Laboratories’s dividend payout ratio is currently 23.97%.

Separately, Zacks Investment Research cut shares of Mesa Laboratories from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 10th.

About Mesa Laboratories

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

5 Day Chart for NASDAQ:MLAB

Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with's FREE daily email newsletter.